The financing will support clinical development of Rgenix’s lead drug candidates, RGX-104 and RGX-202, as well as further development of its therapeutics pipeline. "We are thrilled to have
This is the first program to enter clinical testing out of the discovery collaboration between the two companies. The molecule being advanced in clinical testing was discovered by
The lead investigator of the double-blind placebo-controlled Phase II study is Dr. Tim Wigal. Dr. Wigal has been author or co-author of over 125 peer-reviewed articles about ADHD
The application was filed after the completion of the pre-clinical phase and proof-of-concept of the entourage technology and further to the Company’s preparations towards the development of a
Teva has received post-marketing reports of application site reactions described as burns and scars in patients treated with ZECUITY, and is working in full cooperation with the U.
This trial will study the use of CX-5461, a small molecule G-quadruplex stabilizer, to selectively kill tumors defective in the BRCA1/2 or HR related genes through the concept
The objective of these studies was to establish preliminary efficacy data in vivo for 10 separate repurposing candidates. Each of the candidates were identified using twoXAR’s computational drug
Pharmbio is based in Seoul and specialises in hospital sales of novel pharmaceutical products. Traumakine is in development for the treatment of Acute Respiratory Distress Syndrome (ARDS), a
"With our heritage in both rheumatology and dermatology, we are committed to providing physicians and patients a variety of biologic options, which are critical for the long-term management
The Company also reports that GTL001 drug product has completed stability assays demonstrating a five-year shelf life. As announced on January 7, 2016, Genticel evaluated Roche Molecular Systems’
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.